Isracann Biosciences Inc.
ISCNFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1760
P/E Ratio—
52W High$0.0001
52W Low$0.00001
Isracann Biosciences Inc. (ISCNF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ISCNF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-05 | 2021-05 | 2020-05 | 2019-05 | 2018-05 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B |
| Gross Margin %(computed) | — | — | — | — | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Total Operating Expenses | $0.00B | $0.00B | $0.01B | $0.01B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — | — | -535.45% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.03B) | ($0.02B) | ($0.01B) | ($0.01B) |
| Income Tax Expense | $0.00B | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Net Income | ($0.00B) | ($0.03B) | ($0.02B) | ($0.01B) | ($0.01B) |
| Net Margin %(computed) | — | — | — | — | -636.91% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.03 | $-0.18 | $-0.26 | $-0.75 | $-0.33 |
| Wtd Avg Shares | 0.15B | 0.14B | 0.09B | 0.01B | 0.02B |
| EBITDA | ($0.00B) | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) |
| EBITDA Margin %(computed) | — | — | — | — | -576.88% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · B
Explore more Isracann Biosciences Inc. data
About Isracann Biosciences Inc. (ISCNF) Income Statement
Isracann Biosciences Inc. (ISCNF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, ISCNF reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.00B) — a net profit margin of —.
Frequently asked questions
ISCNF · 4 questionsIsracann Biosciences Inc. (ISCNF) reported revenue of $0.00B for 2022, down —% year-over-year.
ISCNF revenueISCNF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09